关于Syfovre获批用于治疗地图样萎缩。 - Suppr

Suppr

超能文献

Concerning Syfovre Approval for Geographic Atrophy.

作者信息

Schachar Ira H

机构信息

Private practice, Santa Rosa, California.

出版信息

JAMA Ophthalmol. 2024 Feb 1;142(2):85-86. doi: 10.1001/jamaophthalmol.2023.5584.

DOI:10.1001/jamaophthalmol.2023.5584

PMID:38060249

Abstract

摘要

相似文献

Concerning Syfovre Approval for Geographic Atrophy.

JAMA Ophthalmol. 2024 Feb 1;142(2):85-86. doi: 10.1001/jamaophthalmol.2023.5584.

Geographic Atrophy in Age-Related Macular Degeneration.

Dtsch Arztebl Int. 2025 Feb 7;122(3):82-88. doi: 10.3238/arztebl.m2025.0003.

Gene therapy for geographic atrophy in age-related macular degeneration: current insights.

Eye (Lond). 2025 Feb;39(2):274-283. doi: 10.1038/s41433-024-03463-w. Epub 2024 Nov 22.

Alcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: Age-Related Eye Diseases Study 2 Report 34.

Ophthalmol Retina. 2025 Mar;9(3):200-211. doi: 10.1016/j.oret.2024.11.006. Epub 2024 Nov 14.

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.

Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.

Cochrane Database Syst Rev. 2015 Oct 23;2015(10):CD006537. doi: 10.1002/14651858.CD006537.pub3.

Eye (Lond). 2025 Feb;39(2):217-227. doi: 10.1038/s41433-024-03443-0. Epub 2024 Oct 29.

Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration.

BMJ Open Ophthalmol. 2025 Jul 7;10(1):e002105. doi: 10.1136/bmjophth-2024-002105.

Pegcetacoplan (Syfovre) for geographic atrophy in age-related macular degeneration.

Med Lett Drugs Ther. 2023 Apr 3;65(1673):49-50. doi: 10.58347/tml.2023.1673a.

Avacincaptad pegol (Izervay) for geographic atrophy in age-related macular degeneration.

Med Lett Drugs Ther. 2024 Jan 22;66(1694):15-16. doi: 10.58347/tml.2024.1694d.

引用本文的文献

Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications.

Int J Mol Sci. 2025 Aug 6;26(15):7601. doi: 10.3390/ijms26157601.

Effects of taurine, brimonidine and betaxolol on oscillation modulation and stimulation efficiency in degenerated rd10 mouse retinas.

Sci Rep. 2025 Jun 20;15(1):20209. doi: 10.1038/s41598-025-06440-9.

The Complement System as a Therapeutic Target in Retinal Disease.

Medicina (Kaunas). 2024 Jun 5;60(6):945. doi: 10.3390/medicina60060945.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Concerning Syfovre Approval for Geographic Atrophy.

作者信息

Schachar Ira H

机构信息

Private practice, Santa Rosa, California.

出版信息

JAMA Ophthalmol. 2024 Feb 1;142(2):85-86. doi: 10.1001/jamaophthalmol.2023.5584.

DOI:10.1001/jamaophthalmol.2023.5584

PMID:38060249

Abstract

摘要

相似文献

Concerning Syfovre Approval for Geographic Atrophy.

JAMA Ophthalmol. 2024 Feb 1;142(2):85-86. doi: 10.1001/jamaophthalmol.2023.5584.

Geographic Atrophy in Age-Related Macular Degeneration.

Dtsch Arztebl Int. 2025 Feb 7;122(3):82-88. doi: 10.3238/arztebl.m2025.0003.

Gene therapy for geographic atrophy in age-related macular degeneration: current insights.

Eye (Lond). 2025 Feb;39(2):274-283. doi: 10.1038/s41433-024-03463-w. Epub 2024 Nov 22.

Alcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: Age-Related Eye Diseases Study 2 Report 34.

Ophthalmol Retina. 2025 Mar;9(3):200-211. doi: 10.1016/j.oret.2024.11.006. Epub 2024 Nov 14.

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.

Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.

Cochrane Database Syst Rev. 2015 Oct 23;2015(10):CD006537. doi: 10.1002/14651858.CD006537.pub3.

Eye (Lond). 2025 Feb;39(2):217-227. doi: 10.1038/s41433-024-03443-0. Epub 2024 Oct 29.

Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration.

BMJ Open Ophthalmol. 2025 Jul 7;10(1):e002105. doi: 10.1136/bmjophth-2024-002105.

Pegcetacoplan (Syfovre) for geographic atrophy in age-related macular degeneration.

Med Lett Drugs Ther. 2023 Apr 3;65(1673):49-50. doi: 10.58347/tml.2023.1673a.

Avacincaptad pegol (Izervay) for geographic atrophy in age-related macular degeneration.

Med Lett Drugs Ther. 2024 Jan 22;66(1694):15-16. doi: 10.58347/tml.2024.1694d.

引用本文的文献

Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications.

Int J Mol Sci. 2025 Aug 6;26(15):7601. doi: 10.3390/ijms26157601.

Effects of taurine, brimonidine and betaxolol on oscillation modulation and stimulation efficiency in degenerated rd10 mouse retinas.

Sci Rep. 2025 Jun 20;15(1):20209. doi: 10.1038/s41598-025-06440-9.

The Complement System as a Therapeutic Target in Retinal Disease.

Medicina (Kaunas). 2024 Jun 5;60(6):945. doi: 10.3390/medicina60060945.